The Xpovio Myelofibrosis Trial has delivered mixed results, creating both optimism and uncertainty around the future of the therapy. Karyopharm Therapeutics announced that its
The Merck Terns Pharma Acquisition is emerging as one of the most closely watched deals in the pharmaceutical sector, with
The Indian Weight Loss Drug Regulation landscape is undergoing a significant shift as authorities move swiftly to curb the unauthorised sale and
The CVS Insulin Pricing Settlement marks a significant development in the ongoing scrutiny of pharmacy benefit managers and their role
